-
1
-
-
84863985666
-
Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18 years
-
1. Algarni, K.D., Elhenawy, A.M., Maganti, M., et al. Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18 years. J Thorac Cardiovasc Surg 144 (2012), 340–346.
-
(2012)
J Thorac Cardiovasc Surg
, vol.144
, pp. 340-346
-
-
Algarni, K.D.1
Elhenawy, A.M.2
Maganti, M.3
-
2
-
-
39449093040
-
Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the society of thoracic surgery national cardiac database
-
2. Mehta, R.H., Grab, J.D., O'Brien, S.M., et al. Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the society of thoracic surgery national cardiac database. Circulation 117 (2008), 876–885.
-
(2008)
Circulation
, vol.117
, pp. 876-885
-
-
Mehta, R.H.1
Grab, J.D.2
O'Brien, S.M.3
-
3
-
-
83155173970
-
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
3. Hillis, L.D., Smith, P.K., Anderson, J.L., et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124 (2011), e652–e735.
-
(2011)
Circulation
, vol.124
, pp. e652-e735
-
-
Hillis, L.D.1
Smith, P.K.2
Anderson, J.L.3
-
4
-
-
84902479895
-
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
4. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 148 (2014), e1–e132.
-
(2014)
J Thorac Cardiovasc Surg
, vol.148
, pp. e1-e132
-
-
Nishimura, R.A.1
Otto, C.M.2
Bonow, R.O.3
-
5
-
-
84888296344
-
Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis
-
5. Harrison, R.W., Hasselblad, V., Mehta, R.H., et al. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 27 (2013), 1224–1232.
-
(2013)
J Cardiothorac Vasc Anesth
, vol.27
, pp. 1224-1232
-
-
Harrison, R.W.1
Hasselblad, V.2
Mehta, R.H.3
-
6
-
-
84928891158
-
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality
-
6. Greco, T., Calabro, M.G., Covello, R.D., et al. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth, 2015, 10.1093/bja/aeu446.
-
(2015)
Br J Anaesth
-
-
Greco, T.1
Calabro, M.G.2
Covello, R.D.3
-
7
-
-
84930763870
-
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion
-
7. Toller, W., Heringlake, M., Guarracino, F., et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol 84 (2015), 323–336.
-
(2015)
Int J Cardiol
, vol.84
, pp. 323-336
-
-
Toller, W.1
Heringlake, M.2
Guarracino, F.3
-
8
-
-
84902251376
-
Levosimendan improves renal outcome in cardiac surgery: a randomized trial
-
8. Baysal, A., Yanartas, M., Dogukan, M., et al. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth 28 (2014), 586–594.
-
(2014)
J Cardiothorac Vasc Anesth
, vol.28
, pp. 586-594
-
-
Baysal, A.1
Yanartas, M.2
Dogukan, M.3
-
9
-
-
84988963059
-
Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial
-
[Accessed March 7, 2015]
-
9. Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial. https://clinicaltrials.gov/ct2/show/NCT02025621?term=LEVO+CTS&rank=1 [Accessed March 7, 2015].
-
-
-
-
10
-
-
84988959670
-
Levosimendan (Simdax) Investigator's brochure edition 7
-
Orion Pharma; Oxygen Biotherapeutics
-
10. IB, Levosimendan (Simdax) Investigator's brochure edition 7. 2014, Orion Pharma; Oxygen Biotherapeutics.
-
(2014)
-
-
IB1
-
11
-
-
34347387726
-
Clinical pharmacology of levosimendan
-
11. Antila, S., Sundberg, S., Lehtonen, L.A., Clinical pharmacology of levosimendan. Clin Pharmacokinet 46 (2007), 535–552.
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 535-552
-
-
Antila, S.1
Sundberg, S.2
Lehtonen, L.A.3
-
13
-
-
79952607782
-
Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients
-
13. Kivikko, M., Sundberg, S., Karlsson, M.O., et al. Acetylation status does not affect levosimendan's hemodynamic effects in heart failure patients. Scand Cardiovasc J 45 (2010), 86–90.
-
(2010)
Scand Cardiovasc J
, vol.45
, pp. 86-90
-
-
Kivikko, M.1
Sundberg, S.2
Karlsson, M.O.3
-
14
-
-
0036795429
-
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure
-
14. Kivikko, M., Antila, S., Eha, J., et al. Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure. Int J Clin Pharmacol Ther 40 (2002), 465–471.
-
(2002)
Int J Clin Pharmacol Ther
, vol.40
, pp. 465-471
-
-
Kivikko, M.1
Antila, S.2
Eha, J.3
-
15
-
-
58249132859
-
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function
-
15. Eriksson, H.I., Jalonen, J.R., Heikkinen, L.O., et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 87 (2009), 448–454.
-
(2009)
Ann Thorac Surg
, vol.87
, pp. 448-454
-
-
Eriksson, H.I.1
Jalonen, J.R.2
Heikkinen, L.O.3
-
16
-
-
0033696857
-
Myocardial efficiency during levosimendan infusion in congestive heart failure
-
16. Ukkonen, H., Saraste, M., Akkila, J., et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68 (2000), 522–531.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 522-531
-
-
Ukkonen, H.1
Saraste, M.2
Akkila, J.3
-
17
-
-
0031976338
-
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
-
17. Lilleberg, J., Nieminen, M.S., Akkilla, J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 19 (1998), 660–668.
-
(1998)
Eur Heart J
, vol.19
, pp. 660-668
-
-
Lilleberg, J.1
Nieminen, M.S.2
Akkilla, J.3
-
18
-
-
84867485658
-
Preoperative levosimendan decreses mortality and the development of low cardiac output syndrome in high-risk patients with severe left ventricular systolic dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass
-
18. Levin, R., Degrange, M., Del Mazo, C., et al. Preoperative levosimendan decreses mortality and the development of low cardiac output syndrome in high-risk patients with severe left ventricular systolic dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 17 (2012), 125–130.
-
(2012)
Exp Clin Cardiol
, vol.17
, pp. 125-130
-
-
Levin, R.1
Degrange, M.2
Del Mazo, C.3
-
19
-
-
34047270901
-
The effects of levosimendan in cardiac surgery patients with poor left ventricular function
-
19. De Hert, S.G., Lorsomradee, S., Cromheecke, S., et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 104 (2007), 766–773.
-
(2007)
Anesth Analg
, vol.104
, pp. 766-773
-
-
De Hert, S.G.1
Lorsomradee, S.2
Cromheecke, S.3
-
20
-
-
46449138711
-
The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome
-
20. Levin, R., Degrange, M., Del Mazo, C., et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol 61 (2008), 471–479.
-
(2008)
Rev Esp Cardiol
, vol.61
, pp. 471-479
-
-
Levin, R.1
Degrange, M.2
Del Mazo, C.3
-
21
-
-
33644831104
-
Preoperative use of levosimendan in 2 patients with severe aortic stenosis and left ventricular dysfunction
-
21. Prior, D.L., Flaim, B.D., MacIsaac, A.I., et al. Preoperative use of levosimendan in 2 patients with severe aortic stenosis and left ventricular dysfunction. Heart Lung Circ 15 (2006), 56–58.
-
(2006)
Heart Lung Circ
, vol.15
, pp. 56-58
-
-
Prior, D.L.1
Flaim, B.D.2
MacIsaac, A.I.3
-
22
-
-
79951574278
-
Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery
-
22. Leppikangas, H., Järvelä, K., Sisto, T., et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 106 (2011), 298–304.
-
(2011)
Br J Anaesth
, vol.106
, pp. 298-304
-
-
Leppikangas, H.1
Järvelä, K.2
Sisto, T.3
-
23
-
-
84889246150
-
Effectiveness of prophylactic levosimendan in high-risk valve surgery patients
-
23. Ersoy, O., Boysan, E., Unal, E.U., et al. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc J Afr 24 (2013), 260–264.
-
(2013)
Cardiovasc J Afr
, vol.24
, pp. 260-264
-
-
Ersoy, O.1
Boysan, E.2
Unal, E.U.3
-
24
-
-
67649827173
-
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1—coronary artery bypass grafting surgery
-
24. Shahian, D.M., O'Brien, S.M., Filardo, G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1—coronary artery bypass grafting surgery. Ann Thorac Surg 88:1 Suppl. (2009), S2–22.
-
(2009)
Ann Thorac Surg
, vol.88
, Issue.1
, pp. S2-22
-
-
Shahian, D.M.1
O'Brien, S.M.2
Filardo, G.3
-
25
-
-
67649816665
-
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery
-
25. O'Brien, S.M., Shahian, D.M., Filardo, G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 88:1 Suppl. (2009), S23–S42.
-
(2009)
Ann Thorac Surg
, vol.88
, Issue.1
, pp. S23-S42
-
-
O'Brien, S.M.1
Shahian, D.M.2
Filardo, G.3
-
26
-
-
67649786427
-
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3—valve plus coronary artery bypass grafting surgery
-
26. Shahian, D.M., O'Brien, S.M., Filardo, G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3—valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 88:1 Suppl. (2009), S43–S62.
-
(2009)
Ann Thorac Surg
, vol.88
, Issue.1
, pp. S43-S62
-
-
Shahian, D.M.1
O'Brien, S.M.2
Filardo, G.3
-
27
-
-
0018687930
-
A multiple testing procedure for clinical trials
-
27. O'Brien, P.C., Fleming, T.R., A multiple testing procedure for clinical trials. Biometrics 35 (1979), 549–556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.C.1
Fleming, T.R.2
-
28
-
-
0037306242
-
Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis
-
28. Chen, Y.H., DeMets, D.L., Lan, K.K., Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis. Control Clin Trials 24 (2003), 16–27.
-
(2003)
Control Clin Trials
, vol.24
, pp. 16-27
-
-
Chen, Y.H.1
DeMets, D.L.2
Lan, K.K.3
-
29
-
-
36249007028
-
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials
-
29. Hung, H.M., Wang, S.J., O'Neill, R., Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials. J Biopharm Stat 17 (2007), 1201–1210.
-
(2007)
J Biopharm Stat
, vol.17
, pp. 1201-1210
-
-
Hung, H.M.1
Wang, S.J.2
O'Neill, R.3
-
30
-
-
80155211948
-
Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years
-
30. Algarni, K.D., Maganti, M., Yau, T.M., Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years. Ann Thorac Surg 92 (2011), 1678–1684.
-
(2011)
Ann Thorac Surg
, vol.92
, pp. 1678-1684
-
-
Algarni, K.D.1
Maganti, M.2
Yau, T.M.3
-
31
-
-
82455212056
-
Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study
-
31. Williams, J.B., Hernandez, A.F., Li, S., et al. Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study. J Card Surg 26 (2011), 572–578.
-
(2011)
J Card Surg
, vol.26
, pp. 572-578
-
-
Williams, J.B.1
Hernandez, A.F.2
Li, S.3
-
32
-
-
0036673089
-
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta-regression analysis
-
32. Thackray, S., Easthaugh, J., Freemantle, N., et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta-regression analysis. Eur J Heart Fail 4 (2002), 515–529.
-
(2002)
Eur J Heart Fail
, vol.4
, pp. 515-529
-
-
Thackray, S.1
Easthaugh, J.2
Freemantle, N.3
-
33
-
-
45149133687
-
Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses
-
33. Fellahi, J.L., Parienti, J.J., Hanouz, J.L., et al. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 108 (2008), 979–987.
-
(2008)
Anesthesiology
, vol.108
, pp. 979-987
-
-
Fellahi, J.L.1
Parienti, J.J.2
Hanouz, J.L.3
-
34
-
-
79953814462
-
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods
-
34. Mebazaa, A., Parissis, J., Porcher, R., et al. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med 37 (2011), 290–301.
-
(2011)
Intensive Care Med
, vol.37
, pp. 290-301
-
-
Mebazaa, A.1
Parissis, J.2
Porcher, R.3
-
35
-
-
0033635679
-
Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience
-
35. Holman, W.L., Li, Q., Kiefe, C.I., et al. Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience. J Thorac Cardiovasc Surg 120 (2000), 1112–1119.
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 1112-1119
-
-
Holman, W.L.1
Li, Q.2
Kiefe, C.I.3
-
36
-
-
68049088673
-
Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting: a propensity score analysis
-
36. Miceli, A., Fiorani, B., Danesi, T.H., et al. Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting: a propensity score analysis. Interact Cardiovasc Thorac Surg 9 (2009), 291–294.
-
(2009)
Interact Cardiovasc Thorac Surg
, vol.9
, pp. 291-294
-
-
Miceli, A.1
Fiorani, B.2
Danesi, T.H.3
-
37
-
-
77950521752
-
The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome
-
37. Parissis, H., Leotsinidis, M., Akbar, M.T., et al. The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome. J Cardiothorac Surg, 5, 2010, 20.
-
(2010)
J Cardiothorac Surg
, vol.5
, pp. 20
-
-
Parissis, H.1
Leotsinidis, M.2
Akbar, M.T.3
-
38
-
-
34548162441
-
A decade of acute outcomes in post-cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database
-
38. Hernandez, A.F., Grab, J.D., Gammie, J.S., et al. A decade of acute outcomes in post-cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 116 (2007), 606–612.
-
(2007)
Circulation
, vol.116
, pp. 606-612
-
-
Hernandez, A.F.1
Grab, J.D.2
Gammie, J.S.3
-
39
-
-
84902166172
-
Guidance for Industry. Enrichment strategies for clinical trials to support approval of human drugs and biological products
-
[Accessed March 26, 2015]
-
39. Guidance for Industry. Enrichment strategies for clinical trials to support approval of human drugs and biological products. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm332181.pdf [Accessed March 26, 2015].
-
-
-
-
40
-
-
0029030616
-
Report cards on cardiac surgeons. Assessing New York State's approach
-
40. Green, J., Wintfeld, N., Report cards on cardiac surgeons. Assessing New York State's approach. N Engl J Med 332 (1995), 1229–1232.
-
(1995)
N Engl J Med
, vol.332
, pp. 1229-1232
-
-
Green, J.1
Wintfeld, N.2
-
41
-
-
0030027348
-
Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes
-
41. Omoigui, N.A., Miller, D.P., Brown, K.J., et al. Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation 93 (1996), 27–33.
-
(1996)
Circulation
, vol.93
, pp. 27-33
-
-
Omoigui, N.A.1
Miller, D.P.2
Brown, K.J.3
-
42
-
-
33947498821
-
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review
-
42. Van Spall, H.G., Toren, A., Kiss, A., et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297 (2007), 1233–1240.
-
(2007)
JAMA
, vol.297
, pp. 1233-1240
-
-
Van Spall, H.G.1
Toren, A.2
Kiss, A.3
-
43
-
-
84966441045
-
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): rationale and design
-
43. Zangrillo, A., Alvaro, G., Pisano, A., et al. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): rationale and design. Am Heart J 177 (2016), 68–73.
-
(2016)
Am Heart J
, vol.177
, pp. 68-73
-
-
Zangrillo, A.1
Alvaro, G.2
Pisano, A.3
|